NWO Domain Applied and Engineering Sciences (AES) has granted project ULTRA-X-TREME 4 million euros for developing new 3D ultrasound techniques allowing patient-specific diagnosis of vascular problems and prevention of unnecessary operations. The project is led by Chris de Korte, professor of Medical Ultrasound Techniques at Radboudumc and professor of Medical Ultrasound Imaging at the University of Twente.
New techniques
As part of the program Ultrafast Ultrasound Imaging for Extended Diagnosis and Treatment of Vascular Disease (ULTRA-X-TREME), an international research team is to develop new and more accurate three-dimensional vascular wall and perfusion ultrasound imaging techniques. The team has been granted four million euros by the funding instrument Perspectief of NWO Domain AES. In the next five years, under the supervision of Chris de Korte, professor of Medical Ultrasound Techniques at Radboud university medical center and professor of Medical Ultrasound Imaging at the University of Twente, the researchers will develop new ultrasound sensors, contrast agents and analysis techniques to more accurately assess the necessity of vascular treatment.
Consortium
The ULTRA-X-TREME consortium is a collaboration of hospitals, international industrial partners and Dutch research groups with a focus on ultrasound techniques and vascular biomechanics. In alphabetical order, the participants in the program are: ANSYS, Bracco Suisse S.A., Catharina Hospital, Erasmus MC, Harteraad, Mindray, Dutch Society for Vascular Surgery (NVvV), Philips Electronics Netherlands, Pie Medical Imaging, Radboud university medical center, Rijnstate Hospital, Delft University of Technology, Eindhoven University of Technology, TomTec Imaging Systems, University of Twente, Vermon S.A. and Verasonics.
Chris de Korte is member of theme Vascular damage.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
KWF Roadshow 11 November 2019
10 October 2019In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.
read more
More than 3000 visitors at Open Day RIHS
10 October 2019On Sunday 6 October RIHS organized an Open Day in the Weekend of Science (“Weekend van de Wetenschap”) with special guest and television presenter Klaas van Kruistum. More than 3000 visitors became a health scientist for one day and discovered how special healthcare research is.
read more
Dorine Swinkels collaborates with winners of the Nobel Prize in Physiology or Medicine
9 October 2019The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.
read more
Scaling up nanotherapy
7 October 2019Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. Raphael Duivenvoorden, theme Renal disorders, and colleagues, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.
read more
Jubilee lecture and symposium Carl Figdor
3 October 2019For Carl Figdor, theme Cancer development and immune defense, who has been active in the field of tumor immunology for 40 years, a jubilee lecture and symposium will be organised.
read more
‘Smart shirt’ can accurately measure breathing and could be used to monitor lung disease
3 October 2019Denise Mannée and colleagues are developing Hexoskin, a smart shirt that can measure breathing in people. It can reliably measure breathing in healthy people while carrying out activities. This means they can now test out the smart shirts with patients who have COPD.
read more